国立研究開発法人国立成育医療研究センターは、東京都世田谷区にある日本の厚生労働省所管の国立研究開発法人で、国立高度専門医療研究センターである。2010年4月、「高度専門医療に関する研究等を行う独立行政法人に関する法律」に基づき、厚生労働省所管の施設等機関であった旧国立成育医療センターが組織移行する形で発足した。

During the past decade, National Center for Child Health and Development conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 9 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 6 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Center for Child Health and Development" #1 sponsor was "Pfizer" with 7 trials, followed by "Takeda" with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored and "Celgene" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Center for Child Health and Development" #1 collaborator was "Amgen Astellas Biopharma K.K." with 1 trials as a collaborator, "BioMarin/Genzyme LLC" with 1 trials as a collaborator, "Chiba University" with 1 trials as a collaborator, "China Medical University, Taiwan" with 1 trials as a collaborator and "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "National Center for Child Health and Development" are "Colitis, Ulcerative" (3 trials), "Hypertension, Pulmonary" (3 trials), "Crohn Disease" (2 trials), "Eosinophilic Esophagitis" (2 trials) and "Hemophilia A" (2 trials). Many other conditions were trialed in "National Center for Child Health and Development" in a lesser frequency.

Most popular intervention types in "National Center for Child Health and Development" are "Drug" (29 trials), "Biological" (6 trials), "Other" (2 trials), "Dietary Supplement" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "CC-93538" (2 trials), "Ustekinumab" (2 trials), "cyclophosphamide" (2 trials) and "dactinomycin" (2 trials). Other intervention names were less common.

The vast majority of trials in "National Center for Child Health and Development" are 30 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "National Center for Child Health and Development". undefined are not yet recruiting, 12 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in National Center for Child Health and Development, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in National Center for Child Health and Development, 3 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".